Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
68.76 USD | +0.63% | -0.01% | +28.75% |
Jul. 02 | You can't escape politics | |
Jul. 02 | ANALYST RECOMMENDATIONS : Adobe, Nike, Solaredge, Welltower, Spectris... |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 9.23B |
---|---|---|---|---|---|
Net income 2024 * | 227M | Net income 2025 * | 381M | EV / Sales 2024 * | 3.62 x |
Net cash position 2024 * | 262M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 3.2 x |
P/E ratio 2024 * |
41.1
x | P/E ratio 2025 * |
24.5
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.75% |
Latest transcript on Globus Medical, Inc.
1 day | +0.63% | ||
1 week | -0.01% | ||
Current month | +0.18% | ||
1 month | +3.66% | ||
3 months | +29.18% | ||
6 months | +26.12% | ||
Current year | +28.75% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | +6.93% | ||
0.99% | 144 M€ | -2.52% | ||
0.74% | 15 M€ | -4.68% | ||
0.44% | 7 M€ | +2.93% |
Date | Price | Change | Volume |
---|---|---|---|
24-07-10 | 68.62 | +0.42% | 16 827 |
24-07-09 | 68.33 | -0.39% | 433,508 |
24-07-08 | 68.6 | -0.23% | 912,333 |
24-07-05 | 68.76 | +0.20% | 505,867 |
24-07-03 | 68.62 | +0.84% | 389,893 |
Delayed Quote Nyse, July 10, 2024 at 10:23 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.75% | 9.23B | |
-7.35% | 177B | |
-7.04% | 98.58B | |
-9.12% | 64.01B | |
-11.42% | 44.08B | |
+8.12% | 43.79B | |
+17.11% | 43.36B | |
+8.46% | 27.94B | |
+22.05% | 25.79B | |
-9.18% | 23.21B |
- Stock Market
- Equities
- GMED Stock